1. Clinical Overview
A fixed-dose combination (FDC) of two centrally acting agents with complementary mechanisms for the symptomatic treatment of moderate to severe Alzheimer's disease (AD). Donepezil is a reversible, non-competitive acetylcholinesterase inhibitor (AChEI), while Memantine is a low-to-moderate affinity, uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. This combination addresses both cholinergic deficit and glutamatergic excitotoxicity, which are key pathological features of AD. The combination has shown superior efficacy in cognition, global function, and activities of daily living compared to monotherapy in clinical trials, and is a recommended therapeutic strategy in Indian and international guidelines for moderate to severe AD.
| Onset | Duration | Bioavailability |
|---|---|---|
| Donepezil: Cognitive effects may be observed within 4-6 weeks, with full therapeutic benefit often taking up to 12 weeks. Memantine: Clinical effects on behavior and function may be seen within 4 weeks. | Donepezil: Approximately 24-72 hours based on its long half-life. Memantine: Approximately 24 hours. | Donepezil: ~100%. Memantine: ~100%. |
2. Mechanism of Action
The combination exerts a dual, complementary action on two major neurotransmitter systems implicated in Alzheimer's disease pathology. Donepezil increases synaptic acetylcholine concentration by inhibiting its breakdown, thereby enhancing cholinergic neurotransmission, which is crucial for memory and learning. Memantine modulates glutamatergic transmission by blocking NMDA receptors. It preferentially blocks pathologically overactivated NMDA receptors (associated with excitotoxicity and neuronal damage) while allowing normal physiological activation required for synaptic plasticity. This reduces glutamate-mediated excitotoxicity and may have neuroprotective effects.
3. Indications & Uses
- Symptomatic treatment of moderate to severe Alzheimer's disease (AD)
4. Dosage & Administration
Adult Dosage: One tablet (Donepezil 5mg + Memantine 5mg) orally once daily, preferably at bedtime. For Donepezil component: After 4-6 weeks, the dose may be increased to Donepezil 10mg + Memantine 5mg or 10mg based on clinical response and tolerability. Titration should be done under physician supervision.
Administration: Swallow the tablet whole with water, with or without food. Taking it at bedtime may minimize cholinergic side effects like nausea and diarrhea. Do not crush or chew. If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose.
5. Side Effects
Common side effects may include:
- Nausea
- Diarrhea
- Headache
- Dizziness
- Constipation
- Vomiting
- Fatigue
- Anorexia
- Muscle cramps
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Ketoconazole, Itraconazole, Erythromycin | Increase Donepezil plasma levels via CYP3A4/2D6 inhibition, increasing risk of side effects. | Major |
| Carbamazepine, Phenytoin, Rifampicin | Decrease Donepezil plasma levels via CYP450 induction, reducing efficacy. | Moderate |
| Beta-blockers (e.g., Atenolol), Digoxin, Diltiazem | Potentiate bradycardic effects of Donepezil, risk of syncope and falls. | Major |
| Anticholinergic drugs (e.g., Oxybutynin, Amitriptyline) | Counteract the therapeutic effect of Donepezil. | Moderate |
| Cholinergic agonists (e.g., Bethanechol) | Synergistic effect, risk of excessive cholinergic stimulation. | Major |
| Other NMDA antagonists (e.g., Amantadine, Ketamine) | Additive CNS effects with Memantine; increased risk of psychosis, confusion. | Major |
| Drugs that alkalinize urine (e.g., Carbonic Anhydrase Inhibitors, Sodium Bicarbonate) | Decrease renal elimination of Memantine, increasing its levels and toxicity. | Moderate |
| Diuretics (e.g., Hydrochlorothiazide) | May increase Memantine levels. Risk of hyponatremia. | Moderate |
| Antipsychotics (Typical and Atypical) | May antagonize effects of Donepezil. Increased mortality risk in dementia patients. Use with extreme caution. | Major |
7. Patient Counselling
- DO take the tablet exactly as prescribed by your doctor, usually once at bedtime.
- DO inform all your doctors and dentists that you are taking this medicine.
- DO keep a regular follow-up schedule with your neurologist/psychiatrist.
- DO report any falls, fainting episodes, or slow heart rate immediately.
- DONT stop taking the medicine suddenly without consulting your doctor.
- DONT double the dose if you miss one. Take the next dose at the usual time.
- DONT take any other prescription, over-the-counter, or herbal medicine without checking with your doctor or pharmacist.
- DONT consume alcohol while on this medication.
8. Toxicology & Storage
Overdose: Cholinergic crisis (from Donepezil): Severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, respiratory depression, muscle weakness, seizures, loss of consciousness. Memantine overdose: CNS effects like psychosis, hallucinations, agitation, sedation, coma, and cardiovascular instability. Combined overdose presents a mix of these symptoms.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep in the original blister pack or container. Keep out of reach of children and pets. Do not use after the expiry date printed on the pack.